Statistics for Costo-efectividad de pembrolizumab/pemetrexed/platino frente a ipilimumab/nivolumab en pacientes con cáncer de pulmón no escamocelular de células no pequeñas en Colombia.
Total visits
| views | |
|---|---|
| Costo-efectividad de pembrolizumab/pemetrexed/platino frente a ipilimumab/nivolumab en pacientes con cáncer de pulmón no escamocelular de células no pequeñas en Colombia. | 36 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 9 |
| March 2025 | 14 |
| April 2025 | 10 |
| May 2025 | 3 |
File Visits
| views | |
|---|---|
| Costo-efectividad de pembrolizumab/pemetrexed/platino frente a ipilimumab/nivolumab en pacientes con cáncer de pulmón no escamocelular de células no pequeñas en Colombia. | 44 |
Top country views
| views | |
|---|---|
| Colombia | 24 |
| Mexico | 5 |
| Peru | 3 |
| Spain | 2 |
| Argentina | 1 |
| Venezuela | 1 |
Top city views
| views | |
|---|---|
| Bogotá | 9 |
| Medellín | 7 |
| Bucaramanga | 3 |
| Compostela | 3 |
| Barranquilla | 2 |
| Lima | 2 |
| Santiago de Cali | 2 |
| Xalapa | 2 |
| Alicante | 1 |
| Caracas | 1 |
| Chiclayo | 1 |
| Florida | 1 |
| Ibagué | 1 |
| Seville | 1 |